Equities

Procaps Group SA

Procaps Group SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.80
  • Today's Change-0.01 / -0.55%
  • Shares traded28.51k
  • 1 Year change-51.35%
  • Beta0.1553
Data delayed at least 15 minutes, as of Sep 19 2024 20:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2022202220212020
ASSETS
Cash And Short Term Investments43724.23
Total Receivables, Net153141116
Total Inventory977964
Prepaid expenses------
Other current assets, total4.345.840.36
Total current assets297298185
Property, plant & equipment, net113113114
Goodwill, net5.796.806.86
Intangibles, net323028
Long term investments1.722.703.22
Note receivable - long term------
Other long term assets3.084.531.87
Total assets460462360
LIABILITIES
Accounts payable938794
Accrued expenses------
Notes payable/short-term debt0.067.120
Current portion long-term debt/capital leases25875115
Other current liabilities, total181931
Total current liabilities368188240
Total long term debt28179340
Total debt286260455
Deferred income tax7.826.0719
Minority interest(0.94)(0.94)0.78
Other liabilities, total5712816
Total liabilities461500615
SHAREHOLDERS EQUITY
Common stock1.011.012.00
Additional paid-in capital37837854
Retained earnings (accumulated deficit)(346)(388)(287)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(34)(28)(24)
Total equity(0.94)(37)(255)
Total liabilities & shareholders' equity460462360
Total common shares outstanding113113113
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.